title: Properties of the Ca2+ influx reveal the duality of events underlying the activation by vanadate and fluoride of the Gárdos effect in human red blood cells.
abstract: The properties of the 45Ca2+ influx by human red blood cells (RBC) induced by NaVO3 or NaF were compared. The NaVO3-induced 45Ca2+ influx was slower and less extensive than that induced by NaF. Both processes were saturable with Ca2+. Substitution of Na+ by K+ inhibited the 45Ca2+ influx induced by NaVO3 but stimulated that by NaF. The NaVO3-induced Ca2+ influx was sensitive to nifedipine (IC50 = 50 mol/l), Cu2+ (IC50=9 mol/l), DTNB (5,5'-dithiobis-(dinitrobenzoic acid)) (IC50 = 12 mol/l) (maximal inhibition 16%, 18%, and 28%, respectively, if NaF was used as inducer). On the other hand, tetrodotoxin (TTX) and cyclosporin A inhibited only the NaF-induced 45Ca2+ influx (IC50 = 21 mol/l and 28 mol/l, respectively). Pig RBC, known not to display the NaVO3-induced Ca2+ influx, exhibited Ca2+ influx induced by NaF. The results show that NaVO3 activates the Ca2+ influx via a pathway homologous to the L-type Ca2+ channel while the NaF-induced Ca2+ influx is mediated via the TTX-sensitive Na+ channel in the presence of NaF with possible participation of calcineurin or cyclophilin. Thus, the Gardos effect induced by NaVO3 and NaF represents two phenomena activated by different mechanisms present in the cryptic state in the RBC membrane.
authors.affiliation: Department of Biochemistry and Microbiology, Slovak University of Technology, Bratislava. varecka@checdek.chtf.stuba.sk
authors.forename: L
authors.initials: L
authors.lastname: Varecka
authors.forename: E
authors.initials: E
authors.lastname: Peterajová
authors.forename: E
authors.initials: E
authors.lastname: Písová
mesh_terms: D002118:Calcium / Q000097:blood* / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002132:Calcium Radioisotopes; D004228:Dithionitrobenzoic Acid / Q000494:pharmacology; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism*; D005260:Female; D006801:Humans; D007700:Kinetics; D008297:Male; D009543:Nifedipine / Q000494:pharmacology; D011188:Potassium / Q000097:blood; D012969:Sodium Fluoride / Q000494:pharmacology*; D013439:Sulfhydryl Reagents / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology; D014638:Vanadates / Q000494:pharmacology*
chemical_list: D002121:Calcium Channel Blockers; D002132:Calcium Radioisotopes; D013439:Sulfhydryl Reagents; D014638:Vanadates; D013779:Tetrodotoxin; D012969:Sodium Fluoride; D004228:Dithionitrobenzoic Acid; D009543:Nifedipine; D011188:Potassium; D002118:Calcium